This whitepaper summarizes findings from an initiative to assess barriers to health equity for patients with systemic lupus erythematosus (SLE), featuring insights from a panel of health care stakeholders. The experts identified several areas...
This whitepaper summarizes findings from an initiative to assess barriers to health equity for patients with systemic lupus erythematosus (SLE), featuring insights from a panel of health care stakeholders. The experts identified several areas...
Dr Kim, from Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, Missouri, reviews the importance of PrEP in protecting patients on immune-suppressing drugs.
Dr Kim, from Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, Missouri, reviews the importance of PrEP in protecting patients on immune-suppressing drugs.
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
A composite measure of disease activity in axial spondyloarthritis that includes extra-articular manifestations could provide more accurate assessments, researchers say.
A composite measure of disease activity in axial spondyloarthritis that includes extra-articular manifestations could provide more accurate assessments, researchers say.
